Instant access to deep knowledge on biologic drugs

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-rate plans for project- or client-based billing

► Plans and Pricing

Details for Tradename: STELARA

Summary for Tradename: STELARA

Patents:4
Applicants:1
BLAs:1
Suppliers: see list1

Clinical Trials for: STELARA

A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus
Status: Recruiting Condition: Systemic Lupus Erythematosus

A Study to Assess the Effect of Ustekinumab (Stelara®) and Etanercept (Enbrel®) in Participants With Moderate to Severe Psoriasis (MK-0000-206)
Status: Completed Condition: Psoriasis

Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris
Status: Active, not recruiting Condition: Psoriasis

A Pharmacokinetic Study of Single-Dose Intravenous Ustekinumab Delivered in 2 Different Liquid in Vial Formulations
Status: Completed Condition: Healthy

Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease
Status: Active, not recruiting Condition: Graft vs. Host Disease

A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Status: Recruiting Condition: Colitis, Ulcerative; Inflammatory Bowel Diseases

A Study of the Safety and Efficacy of Ustekinumab in Adolescent Patients With Psoriasis (CADMUS)
Status: Completed Condition: Psoriasis

An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than 6 to Less Than 12 Years of Age
Status: Not yet recruiting Condition: Psoriasis

A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Participants With Active Radiographic Axial Spondyloarthritis
Status: Recruiting Condition: Axial Spondyloarthritis

A Study on Assessment of STELARA and Tumor Necrosis Factor Alpha Inhibitor Therapies in Participants With Psoriatic Arthritis
Status: Recruiting Condition: Psoriatic Arthritis

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Ingredient Dosage Form BLA Approval Date Patent No. Assignee Inventors Estimated Patent Expiration (20y From Filing) Status Orphan Source
Centocor Ortho Biotech Inc
STELARA
ustekinumab
INJECTABLE; INJECTION125261Sep 25, 20098,828,668 The Board of Trustees of the Leland Stanford Junior University (Palo Alto, CA) Axtell; Robert C. (Menlo Park, CA), Steinman; Lawrence (Stanford, CA), Han; May H. (Menlo Park, CA), de Jong; Brigit A. (Nijmegen, NL), Raman; Chander (Birmingham, AL), Walker; Michael (Carlsbad, CA), Shi; Jing (Carlsbad, CA) <disabled in preview>Active Rxsearch
Centocor Ortho Biotech Inc
STELARA
ustekinumab
INJECTABLE; INJECTION125261Sep 25, 20098,420,081 AbbVie, Inc. (North Chicago, IL) Fraunhofer; Wolfgang (Shrewsbury, MA), Bartl; Annika (Ludwigshafen, DE), Krause; Hans-juergen (Grunstadt, DE), Tschoepe; Markus (Hessheim, DE), Kaleta; Katharina (Ludwigshafen, DE) <disabled in preview>Active Rxsearch
Centocor Ortho Biotech Inc
STELARA
ustekinumab
INJECTABLE; INJECTION125261Sep 25, 20098,962,804 City of Hope (Duarte, CA) Williams; John C. (Monrovia, CA), Horne; David A. (Duarte, CA), Ma; Yuelong (Duarte, CA), Chang; Heng Wei (Foster City, CA), Donaldson; Joshua Michael (Lumberton, NJ), Zer; Cindy (Duarte, CA), Bzymek; Krzysztof (Pasadena, CA), Avery; Kendra Nicole (Pasadena, CA), Xie; Jun (Duarte, CA) <disabled in preview>Active Rxsearch
This preview shows a limited data set.
Complete access is available with a Subscription

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2016 thinkBiotech LLC

Connect with Social Media:

Follow @BiologicPatents on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc